市場調查報告書

軟組織異體移植片的全球市場 - 成長,趨勢,預測(2019年∼2024年)

Soft Tissue Allografts Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 707236
出版日期 內容資訊 英文 111 Pages
商品交期: 2-3個工作天內
價格
Back to Top
軟組織異體移植片的全球市場 - 成長,趨勢,預測(2019年∼2024年) Soft Tissue Allografts Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年09月01日內容資訊: 英文 111 Pages
簡介

起因於田徑運動和接觸運動等的損傷所使用的軟組織異體移植片的需求高漲,及軟組織修復及置換技術的發展,老年人口的增加等,促進軟組織異體移植片市場成長。

本報告提供全球軟組織異體移植片市場調查,市場概要,各類型、用途、終端用戶、地區的市場規模的變化與預測,市場成長要素及阻礙因素分析,市場機會,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 老年人的增加
    • 田徑運動以及其他運動的軟組織異體移植片的需求增加
    • 軟組織置換技術的進步
  • 市場阻礙因素
    • 治療費高
    • 複雜的償付制度
  • 波特的五力分析
    • 買方議價能力
    • 供給企業談判力
    • 新加入業者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係

第5章 市場區隔

  • 各類型
    • 軟骨異體移植片
    • 肌腱異體移植片
    • 半月軟骨異體移植片
    • 牙科異體移植片
    • 其他
  • 各用途
    • 整形外科
    • 牙科
    • 創傷護理
    • 其他
  • 各終端用戶
    • 醫院
    • 審美中心
    • 整形外科
    • 牙科醫院
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Allergan Plc
    • B. Braun Melsungen AG
    • Conmed Corporation
    • Xtant Medical Holdings, Inc.
    • Alliqua BioMedical, Inc.
    • AlonSource Group
    • Becton Dickinson and Company
    • Arthrex, Inc.
    • Bone Bank Allografts
    • Osiris Therapeutics, Inc.
    • Integra LifeSciences Corporation
    • Stryker Corporation

第7章 市場機會及未來趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 62796

Market Overview

Rising demand for Soft Tissue Allografts in athletics & other sports is contributing largely to the market growth. Modern training regimens in athletics, field events and a number of other contact sports like the American football, require athletes to undergo intensive training sessions which are in practice more strenuous than the actual sport itself.

High-intensity training regimens are directly correlated with athletic performance improvement but excessive training also induces muscle and bone fatigue and often leads to injury. Consequently, injury prevalence among athletes has been increasing especially due to excessive training. The competitive nature of sports has spurred the demand among athletes for quick recovery and easily accessible modalities to treat musculoskeletal injuries.

As a result, the demand for soft tissue allografts has been increasing in athletics and other contact sports, which in turn is fuelling the growth of the global soft tissue allografts market. Other factors contributing to the growth of this market include the scientific advancements in soft tissue repair and replacement and an increasing geriatric population.

Scope of the Report

Soft tissue allografts are the substitute tissues, having application in the reconstruction of deficient ligaments, spinal surgeries, torn menisci, and osteochondral defects during knee surgeries.

Key Market Trends

Dentistry is Expected to Witness a Healthy Growth Over the Forecast Period

In countries such as India, Australia, the United States, etc., more attention is given to the aesthetics and this results in rising aesthetic procedures. Dentistry is the sector which is currently witnessing a large number of aesthetic procedures to improve dental appearance.

Along with that, dental disorders such as Periodontitis are also on the rise. For instance, the National Institute of Health has stated that periodontitis is affecting around 20-50% of the global population. Also, NIH has stated that around 44% of the people aged 65 and more are prone to have periodontal disease. Therefore, the need for proper treatment has increased.

The soft tissue allografts are used to stop the gum recession and to improve the appearance of the same. Along with the improved gum aesthetics, soft tissues are also beneficial in curing the periodontal disease which is augmenting the demand for the same across the globe. hence, it is indicated that the dentistry segment will show satisfactory growth over the forecast period.

North America Dominates the Market

The global soft tissue allografts market has been segmented into five major regions, viz. North America, Europe, Asia Pacific, Middle East & Africa, and South America.

Driven by the United States, North America is expected to dominate the market in the coming future. This is majorly due to factors such as increasing prevalence of diabetic foot ulcers, better healthcare awareness program for diabetes and an increase in a number of surgical procedures on anterior cruciate ligament (ACL). Furthermore, technological development in dental implants and increasing expenditure by major & small key players for the development of soft tissue allografts are also boosting the growth of the market studied in the North America region.

Competitive Landscape

The soft tissue allografts market is moderately competitive and many of the global players are into the market. For instance, Allergan Plc., B. Braun Melsungen AG, Conmed Corporation, etc. are providing these products across the globe. Also, new product launches from these players are augmenting the demand for these products.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Geriatric Population
    • 4.2.2 Increasing Demand for Soft Tissue Allografts in Athletics and Other Sports
    • 4.2.3 Advancements in Soft Tissue Replacement
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Treatment
    • 4.3.2 Complicated Reimbursement Policies
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 Cartilage Allograft
    • 5.1.2 Tendon Allograft
    • 5.1.3 Meniscus Allograft
    • 5.1.4 Dental Allograft
    • 5.1.5 Others
  • 5.2 By Application
    • 5.2.1 Orthopedic
    • 5.2.2 Dentistry
    • 5.2.3 Wound Care
    • 5.2.4 Others
  • 5.3 By End-User
    • 5.3.1 Hospitals
    • 5.3.2 Aesthetic Centres
    • 5.3.3 Orthopedic Clinics
    • 5.3.4 Dental Clinics
    • 5.3.5 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Allergan Plc
    • 6.1.2 B. Braun Melsungen AG
    • 6.1.3 Conmed Corporation
    • 6.1.4 Xtant Medical Holdings, Inc.
    • 6.1.5 Alliqua BioMedical, Inc.
    • 6.1.6 AlonSource Group
    • 6.1.7 Becton Dickinson and Company
    • 6.1.8 Arthrex, Inc.
    • 6.1.9 Bone Bank Allografts
    • 6.1.10 Osiris Therapeutics, Inc.
    • 6.1.11 Integra LifeSciences Corporation
    • 6.1.12 Stryker Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top